No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients

Overview of attention for article published in Frontiers in Molecular Neuroscience, October 2018

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

The clinical course of relapsing-remitting multiple sclerosis (RRMS) is highly heterogeneous and prognostic biomarkers at time…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.